Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02639091
Title Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Age Groups: adult | senior
Covered Countries USA | ITA

Facility Status City State Zip Country Details
Chicago Illinois 60637 United States Details
Bethesda Maryland 20892 United States Details
Detroit Michigan 48202 United States Details
Charleston South Carolina 29425 United States Details
Milano Lombardia 20089 Italy Details
Milano Lombardia 20133 Italy Details
*Shaded cells indicate that there was no data available from for the field